Abstract
Inflammatory biomarkers have been very useful in detecting and monitoring inflammatory processes along with providing helpful information to select appropriate therapeutic strategies. C-reactive protein (CRP) is a nonspecific, but quite useful medical acute inflammatory biomarker and is associated with persistent chronic inflammatory processes. Several studies suggest that different levels of CRP are correlated with neurological disorders such as Alzheimer’s disease (AD). However, dynamics of CRP levels have also been observed in virus/bacterial-related infections leading to inflammatory responses and this triggers mTOR-mediated pathways for neurodegeneration diseases. The biophysical structural transition from CRP to monomeric CRP (mCRP) and the significance of the ratio of CRP levels on the onset of symptoms associated with inflammatory response have been discussed. In addition, mTOR inhibitors act as immunomodulators by downregulating the expression of viral infection and can be explored as a potential therapy for neurological diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
Not applicable.
References
Agrawal A, Singh PP, Bottazzi B et al (2009) Pattern recognition by pentraxins. Adv Exp Med Biol 653:98–116. https://doi.org/10.1007/978-1-4419-0901-5_7
Agarwal D, Kumari R, Ilyas A et al (2021) Crosstalk between epigenetics and mTOR as a gateway to new insights in pathophysiology and treatment of Alzheimer's disease. Int J Biol Macromol 192:895–903. https://doi.org/10.1016/j.ijbiomac.2021.10.026
Ahmad I, Hoque M, Alam SSM et al (2023) Curcumin and plumbagin synergistically target the PI3K/Akt/mTOR pathway: a prospective role in cancer treatment. Int J Mol Sci 24(7):6651. https://doi.org/10.3390/ijms24076651
Ali N (2020) Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol 92(11):2409–2411. https://doi.org/10.1002/jmv.26097
Anchah L, Hassali MA, Lim MS, Ibrahim MI, Sim KH, Ong TK (2017) Health related quality of life assessment in acute coronary syndrome patients: the effectiveness of early phase I cardiac rehabilitation. Health Qual Life Outcomes 15(1):10. https://doi.org/10.1186/s12955-016-0583-7
Ansar W (2020) Multiple faces of C-reactive protein: structure-function relationships. Clin Sign C-React Protein 1:1–34
Ansar W, Ghosh S, Ansar W, Ghosh S (2016) CRP: historical perspective, structure, evolution, synthesis, clinical and biological functions. Biol React Protein Health Dis 1:33–43
Araki K, Turner AP, Shaffer VO et al (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460(7251):108–112. https://doi.org/10.1038/nature08155
Awogbindin IO, Ben-Azu B, Olusola BA et al (2021) Microglial implications in SARS-CoV-2 infection and COVID-19: Lessons from viral RNA neurotropism and possible relevance to Parkinson’s disease. Front Cell Neurosci. https://doi.org/10.3389/fncel.2021.670298
Aziz M, Fatima R, Assaly R (2020) Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol 92(11):2283–2285. https://doi.org/10.1002/jmv.25948
Baldi S, Pinna GD, Mombaruzzo P et al (2008) C-reactive protein correlates with tissue oxygen availability in patients with stable COPD. Int J COPD 3(4):745–751. https://doi.org/10.2147/copd.s3819
Balin BJ, Gérard HC, Arking EJ, Appelt DM, Branigan PJ et al (1998) (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain. Med Microbiol Immunol 187(1):23–42. https://doi.org/10.1007/s004300050071
Bansal T, Pandey A et al (2014) C-reactive protein (CRP) and its association with periodontal disease: a brief review. J Clin Diagn Res JCDR 8(7):21–24. https://doi.org/10.7860/JCDR/2014/8355.4646
Behl T, Rana T, Sehgal A, et al (2022) Phytochemicals targeting nitric oxide signaling in neurodegenerative diseases. Nitric oxide.
Bohmwald K, Gálvez NMS, Canedo-Marroquín G et al (2019) Contribution of cytokines to tissue damage during human respiratory syncytial virus infection. Front Immunol 10:1–16. https://doi.org/10.3389/fimmu.2019.00452
Boncler M, Wu Y, Watala C (2019) The multiple faces of C-reactive protein: physiological and pathophysiological implications in cardiovascular disease. Molecules 24(11):2062
Braig D, Nero TL, Koch HG et al (2017) Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites. Nat Commun. https://doi.org/10.1038/ncomms14188
Bunton-Stasyshyn RKA, Saccon RA, Fratta P et al (2015) SOD1 function and its implications for amyotrophic lateral sclerosis pathology: new and renascent themes. Neuroscientist 21(5):519–529. https://doi.org/10.1177/1073858414561795
Chang MK, Binder CJ, Torzewski M, Witztum JL (2002) C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 99(20):13043–13048. https://doi.org/10.1073/pnas.192399699
Chien JY, Hsueh PR, Cheng WC, Yu CJ, Yang PC (2006) Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome. Respirology 11(6):715–722. https://doi.org/10.1111/j.1440-1843.2006.00942.x
Corradetti MN, Guan KL (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25(48):6347–6360
Crino PB (2016) The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol 12(7):379–392. https://doi.org/10.1038/nrneurol.2016.81
Das S, Roy S, Kaul S et al (2014) CRP gene (1059G>C) polymorphism and its plasma levels in ischemic stroke and hemorrhagic stroke in a South Indian population. Inflammation 37(5):1683–1688. https://doi.org/10.1007/s10753-014-9897-y
Das A, Reis F, Maejima Y et al. (2017). mTOR signaling in cardiometabolic disease, cancer, and aging. In: Oxidative medicine and cellular longevity. https://doi.org/10.1155/2017/6018675
De Chiara G, Marcocci ME, Sgarbanti R, Civitelli L et al (2012) Infectious agents and neurodegeneration. Mol Neurobiol 46(3):614–638. https://doi.org/10.1007/s12035-012-8320-7
De-Paula VJ, Radanovic M, Diniz BS et al (2012) Alzheimer’s disease. Subcell Biochem 65:329–352. https://doi.org/10.1007/978-94-007-5416-4_14
Devaraj S, du Clos TW, Jialal I (2005) Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol 25(7):1359–1363. https://doi.org/10.1161/01.ATV.0000168573.10844.ae
Du Clos TW (2013) Pentraxins: structure, function, and role in inflammation. ISRN Inflamm 2013:1–22. https://doi.org/10.1155/2013/379040
Duong T, Nikolaeva M, Acton PJ (1997) C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer’s disease. Brain Res 749(1):152–156. https://doi.org/10.1016/S0006-8993(96)01359-5
Eisenhardt SU, Thiele JR, Bannasch H et al (2009) C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle 8(23):3885–3892. https://doi.org/10.4161/cc.8.23.10068
Francois A, Verite J, Bilan AR et al. (2016) The mTOR signaling pathway in neurodegenerative diseases. In: Molecules to medicine with MTOR: translating critical pathways into novel therapeutic strategies, pp 85–104. https://doi.org/10.1016/B978-0-12-802733-2.00011-6
Gao R, Wang L, Bai T et al (2017) C-reactive protein mediating immunopathological lesions: a potential treatment option for severe influenza A diseases. EBioMedicine 22:133–142
Gao Y, Li T, Han M et al (2020) Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol 92(7):791–796. https://doi.org/10.1002/jmv.25770
Gatti P, Ilamathi HS, Todkar K et al (2020) Mitochondria targeted viral replication and survival strategies—prospective on SARS-CoV-2. Front Pharmacol. https://doi.org/10.3389/fphar.2020.578599
Gendrel D, Raymond J, Coste J et al (1999) Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs viral infections. Pediatr Infect Dis J 18(10):875–881. https://doi.org/10.1097/00006454-199910000-00008
Gong C, Wei D, Wang Y, Ma J et al (2016) A meta-analysis of C-reactive protein in patients with Alzheimer’s disease. Am J Alzheimers Dis Other Demen 31(3):194–200. https://doi.org/10.1177/1533317515602087
Hao S, Wang Y, Gao G, Li Z (2017) Hepatitis B virus upregulates the expression of C-reactive protein both in vivo and in vitro. Ann Clin Lab Sci 47(4):432–435
Hara K, Maruki Y, Long X et al (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110(2):177–189
Hein TW, Qamirani E, Ren Y et al (2014) Selective activation of lectin-like oxidized low-density lipoprotein receptor-1 mediates C-reactive protein-evoked endothelial vasodilator dysfunction in coronary arterioles. Circ Res 114(1):92–100. https://doi.org/10.1161/CIRCRESAHA.114.301763
Iwamoto N, Nishiyama E, Ohwada J et al (1994) Demonstration of CRP immunoreactivity in brains of Alzheimer’s disease: immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci Lett 177(1–2):23–26. https://doi.org/10.1016/0304-3940(94)90035-3
Jabir NR, Rehman MT, Alsolami K et al (2021a) Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer’s treatment. Ann Med 53(1):2332–2344. https://doi.org/10.1080/07853890.2021.2009124
Jabir NR, Rehman MT, Tabrez S et al (2021b) Identification of butyrylcholinesterase and monoamine oxidase B targeted ligands and their putative application in alzheimer’s treatment: a computational strategy. Curr Pharm Des 27(20):2425–2434. https://doi.org/10.2174/1381612827666210226123240
Jabir NR, Shakil S, Tabrez S et al (2021c) In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer’s disease. J Biomol Struct Dyn 39(14):5083–5092. https://doi.org/10.1080/07391102.2020.1784796
Jain S, Gautam V, Naseem S (2011) Acute-phase proteins: as diagnostic tool. J Pharm Bioallied Sci 3(1):118–127. https://doi.org/10.4103/0975-7406.76489
Jeon J-S, Rheem I, Kim JK (2017) C-reactive protein and respiratory viral infection. Korean J Clin Lab Sci 49(1):15–21. https://doi.org/10.15324/kjcls.2017.49.1.15
Kaplan M, Hamoud S, Tendler Y et al (2014) A significant correlation between C-reactive protein levels in blood monocytes derived macrophages versus content in carotid atherosclerotic lesions. J Inflamm 11:7. https://doi.org/10.1186/1476-9255-11-7
Karam BS, Morris RS, Bramante CT et al (2021) mTOR inhibition in COVID-19: a commentary and review of efficacy in RNA viruses. J Med Virol 93(4):1843–1846. https://doi.org/10.1002/jmv.26728
Kaur D, Behl T, Sehgal A et al (2021) Decrypting the potential role of α-lipoic acid in Alzheimer’s disease. Life Sci 284:119899
Khan N (2021) mTOR: a possible therapeutic target against SARS-CoV-2 infection. Arch Stem Cell Ther 2(1):5–7
Kulinski JM, Tarakanova VL, Verbsky J (2013) Regulation of antiviral CD8 T-cell responses. Crit Rev Immunol 33(6):477–488. https://doi.org/10.1615/CritRevImmunol.2013007909
Kuss-Duerkop SK, Wang J, Mena I et al (2017) Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late-stage replication. PLoS Pathog 13(9):e1006635. https://doi.org/10.1371/journal.ppat.1006635
Lannergård A, Larsson A, Kragsbjerg P, Friman G (2003) Correlations between serum amyloid A protein and C-reactive protein in infectious diseases. Scand J Clin Lab Invest 63(4):267–272
Largman-Chalamish M, Wasserman A, Silberman A et al (2022) Differentiating between bacterial and viral infections by estimated CRP velocity. PLoS ONE 17(12):e0277401. https://doi.org/10.1371/journal.pone.0277401
Le Sage V, Cinti A, Amorim R (2016) Adapting the stress response: Viral subversion of the mTOR signaling pathway. Viruses 8(6):152
Levinson T, Tamir N, Shenhar-Tsarfaty S et al (2020) The potential beneft of a second C-reactive protein measurement in patients with gram-negative bacteraemia presenting to the emergency medicine department. Biomarkers 25:533–538
Lipton JO, Sahin M (2014) The neurology of mTOR. Neuron 84(2):275–291. https://doi.org/10.1016/j.neuron.2014.09.034
Lobo SM (2012) Sequential C-reactive protein measurements in patients with serious infections: Does it help? Crit Care 16(3):130
Luan YY, Yao YM (2018) The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases. Front Immunol 9:1–8. https://doi.org/10.3389/fimmu.2018.01302
Luan Y, Yin C, Yao Y (2021) Update advances on C-reactive protein in COVID-19 and other viral infections. Front Immunol. https://doi.org/10.3389/fimmu.2021.720363
Luo X, Zhou W, Yan X et al (2020) Prognostic value of C-reactive protein in patients with COVID-19. Clin Infect Dis. https://doi.org/10.1101/2020.03.21.20040360
Lv JM, Wang MY (2018) In vitro generation and bioactivity evaluation of C-reactive protein intermediate. PLoS ONE 13(5):1–13. https://doi.org/10.1371/journal.pone.0198375
Ma LN, Liu XY, Luo X et al (2015) Serum high-sensitivity C-reactive protein are associated with HBV replication, liver damage and fibrosis in patients with chronic hepatitis B. Hepatogastroenterology 62(138):368–372
Maiese K (2016) Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Br J Clin Pharmacol 1:1245–1266. https://doi.org/10.1111/bcp.12804
Maiese K (2020) The mechanistic target of rapamycin (mTOR): novel considerations as an antiviral treatment. Curr Neurovasc Res 17(3):332–337. https://doi.org/10.2174/1567202617666200425205122
Marchesi VT (2005) An alternative interpretation of the amyloid Abeta hypothesis with regard to the pathogenesis of Alzheimer’s disease. Proc Natl Acad Sci USA 102(26):9093–9098. https://doi.org/10.1073/pnas.0503181102
Marnell L, Mold C, Du Clos TW (2005) C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117(2):104–111. https://doi.org/10.1016/j.clim.2005.08.004
Mashayekhi-Sardoo H, Hosseinjani H (2022) A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19. J Basic Clin Physiol Pharmacol 33(1):17–25. https://doi.org/10.1515/jbcpp-2020-0495
McFadyen JD, Kiefer J, Braig D et al (2018) Dissociation of C-reactive protein localizes and amplifies inflammation: evidence for a direct biological role of C-reactive protein and its conformational changes. Front Immunol. https://doi.org/10.3389/fimmu.2018.01351
McGavern DB, Kang SS (2011) Illuminating viral infections in the nervous system. Nat Rev Immunol 1(5):318–329. https://doi.org/10.1038/nri2971
Mo P, Xing Y, Xiao Y et al (2020) Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa270
Montero JC, Chen X, Ocaña A, Pandiella A (2012) Predominance of mTORC1 over mTORC2 in the regulation of proliferation of ovarian cancer cells: therapeutic implications. Mol Cancer Ther 11(6):1342–1352. https://doi.org/10.1158/1535-7163
Moura TCF, Amoras ESG, Queiroz MAF et al (2019) Association of serum levels of c-reactive protein with CRP-717 T/c polymorphism and viremia in HCV and HBV carriers. Rev Soc Bras Med Trop 52:1–6. https://doi.org/10.1590/0037-8682-0455-2018
Mueed Z, Tandon P, Maurya SK et al (2019) Tau and mTOR: the hotspots for multifarious diseases in Alzheimer's development. Front Neurosci 12. https://doi.org/10.3389/fnins.2018.01017
Pan F, Ye T, Sun P et al (2020) Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology 295(3):715–721. https://doi.org/10.1148/radiol.2020200370
Paran Y, Yablecovitch D, Choshen G et al (2009) C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department. Crit Care 13(2):1–10
Park S, Chapuis N, Tamburini J, Bardet V, Cornillet-Lefebvre P, Willems L et al (2010) Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia. Haematologica 95(5):819
Pei JJ, Hugon J (2008) mTOR-dependent signalling in Alzheimer’s disease. J Cell Mol Med 12(6B):2525–2532. https://doi.org/10.1111/j.1582-4934.2008.00509.x
Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Investig 111(12):1805–1812. https://doi.org/10.1172/JCI200318921
Perez A et al (2020) Presentation of severe acute respiratory syndrome-coronavirus 2 infection as cholestatic jaundice in two healthy adolescents. J Pediatr 226:278–280
Poddar NK, Agarwal D, Agrawal Y et al (2022) Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: a current update on molecular mechanisms and combination therapy. Biochim Biophys Acta Mol Basis Dis BBA-MOL BASIS DIS 1868(11):166524. https://doi.org/10.1016/j.bbadis.2022.166524
Prins BP, Abbasi A, Wong A, Vaez A, Nolte I, Franceschini N, Stuart PE, Guterriez Achury J, Mistry V, Bradfield JP, Valdes AM (2016) Investigating the causal relationship of C-reactive protein with 32 complex somatic and psychiatric outcomes: a large-scale cross-consortium Mendelian randomization study. PLoS Med 13(6):e1001976
Rabanal-Ruiz Y, Korolchuk VI (2018) mTORC1 and nutrient homeostasis: the central role of the lysosome. Int J Mol Sci. https://doi.org/10.3390/ijms19030818
Radbel J, Narayanan N, Bhatt PJ (2020) Use of tocilizumab for COVID-19-induced cytokine release syndrome: a cautionary case report. Chest 158(1):e15–e19. https://doi.org/10.1016/J.CHEST.2020.04.024
Rai PK (2022) Current Overviews on COVID-19 Management Strategies. Curr Pharm Biotechnol 23(3);361-387. https://doi.org/10.2174/1389201022666210509022313
Sait A, Angeli C, Doig AJ et al (2021) Viral involvement in Alzheimer’s disease. ACS Chem Neurosci 12(7):1049–1060. https://doi.org/10.1021/acschemneuro.0c00719
Salazar J, Martínez MS, Chávez-Castillo M et al (2014) C-reactive protein: an in-depth look into structure, function, and regulation. Int Sch Res Not 2014:653045. https://doi.org/10.1155/2014/653045
Salinas S, Schiavo G, Kremer EJ (2010) A hitchhiker’s guide to the nervous system: the complex journey of viruses and toxins. Nat Rev Microbiol 8(9):645–655. https://doi.org/10.1038/nrmicro2395
Serrano-Pozo A, William CM, Ferrer I et al (2010) Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology. Brain 133(Pt 5):1312–1327. https://doi.org/10.1093/brain/awq056
Serrano-Pozo A, Frosch MP, Masliah E et al (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. https://doi.org/10.1101/cshperspect.a006189
Sharifpour M, Rangaraju S, Liu M et al (2020) C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19. PLoS ONE 15:1–10. https://doi.org/10.1371/journal.pone.0242400
Sharma H, Ilyas A, Chowdhury A, Poddar NK, Chaudhary AA, Shilbayeh SAR, Ibrahim AA, Khan S (2022) Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India. BMC Public Health 22:1402. https://doi.org/10.1186/s12889-022-13720-w
Sheriff A, Kayser S, Brunner P et al (2021) C-reactive protein triggers cell death in ischemic cells. Front Immunol 12:1–8. https://doi.org/10.3389/fimmu.2021.630430
Sierra R, Rello J, Bailén MA et al (2004) C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome. Intensive Care Med 30(11):2038–2045. https://doi.org/10.1007/s00134-004-2434-y
Slaats J, ten Oever J, van de Veerdonk FL et al (2016) IL-1β/IL-6/CRP and IL-18/ferritin: distinct inflammatory programs in infections. PLoS Pathog 12(12):1–13. https://doi.org/10.1371/journal.ppat.1005973
Sochocka M, Zwolińska K, Leszek J (2017) The infectious etiology of alzheimer’s disease. Curr Neuropharmacol 15(7):996–1009. https://doi.org/10.2174/1570159x15666170313122937
Song IU, Cho HJ, Kim JS et al (2014) Serum hs-CRP levels are increased in de novo parkinson’s disease independently from age of onset. Eur Neurol 72(5–6):285–289. https://doi.org/10.1159/000363570
Sproston NR, Ashworth JJ (2018) Role of C-reactive protein at sites of inflammation and infection. Front Immunol 9:1–11. https://doi.org/10.3389/fimmu.2018.00754
Stein MP, Edberg JC, Kimberly RP et al (2000) C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific. J Clin Investig 105(3):369–376. https://doi.org/10.1172/JCI7817
Strang F, Scheichl A, Chen YC et al (2012) Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer’s disease? Brain Pathol 22(3):337–346. https://doi.org/10.1111/j.1750-3639.2011.00539.x
Strauss L, Whiteside TL, Knights A et al (2007) Selective survival of naturally occurring human CD4 + CD25 + Foxp3 + regulatory T cells cultured with rapamycin. J Immunol 178(1):320–329. https://doi.org/10.4049/jimmunol.178.1.320
Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR (2011) Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res 1399:96–115. https://doi.org/10.1016/j.brainres.2011.05.015
Subramanian A, Tamilanban T, Alsayari A et al (2022) Trilateral association of autophagy, mTOR and Alzheimer’s disease: potential pathway in the development for Alzheimer’s disease therapy. Front Pharmacol 13:1094351. https://doi.org/10.3389/fphar.2022.1094351
Tan L, Sato N, Shiraki A et al (2019) Everolimus delayed and suppressed cytomegalovirus DNA synthesis, spread of the infection, and alleviated cytomegalovirus infection. Antiviral Res 162:30–38
Tattoli I, Philpott DJ, Girardin SE (2012) The bacterial and cellular determinants controlling the recruitment of mTOR to the Salmonella-containing vacuole. Biol Open 1(12):1215–1225. https://doi.org/10.1242/bio.20122840
ten Oever J, Tromp M, Bleeker-Rovers CP, Joosten LA et al (2012) Combination of biomarkers for the discrimination between bacterial and viral lower respiratory tract infections. J Infect 65(6):490–495. https://doi.org/10.1016/j.jinf.2012.08.004
Terrazzano G, Rubino V, Palatucci AT et al (2020) An open question: is it rational to inhibit the mtor-dependent pathway as COVID-19 therapy? Front Pharmacol 11:1–5. https://doi.org/10.3389/fphar.2020.00856
Thompson D, Pepys MB, Wood SP (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7(2):169–177. https://doi.org/10.1016/S0969-2126(99)80023-9
Thurnham DI, McCabe GP, Northrop-Clewes CA, Nestel P (2003) Effects of subclinical infection on plasma retinol concentrations and assessment of prevalence of vitamin A deficiency: meta-analysis. Lancet 362(9401):2052–2058. https://doi.org/10.1016/s0140-6736(03)15099-4
Towfighi A, Cheng EM, Ayala-Rivera M et al (2017) Randomized controlled trial of a coordinated care intervention to improve risk factor control after stroke or transient ischemic attack in the safety net: secondary stroke prevention by uniting community and chronic care model teams early to end disparities (SUCCEED). BMC Neurol 17:24. https://doi.org/10.1186/s12883-017-0792-7
van de Veerdonk FL, Wever PC, Hermans MH, Fijnheer R, Joosten LA, van der Meer JW, Netea MG, Schneeberger PM (2012) IL-18 serum concentration is markedly elevated in acute EBV infection and can serve as a marker for disease severity. J Infect Dis 206(2):197–201. https://doi.org/10.1093/infdis/jis335
van de Weg CA, Huits RM, Pannuti CS et al (2014) (2014) Hyperferritinaemia in dengue virus infected patients is associated with immune activation and coagulation disturbances. PLoS Negl Trop Dis 8(10):e3214. https://doi.org/10.1371/journal.pntd.0003214
Venge P, Douhan-Håkansson L, Garwicz D et al (2015) Human neutrophil lipocalin as a superior diagnostic means to distinguish between acute bacterial and viral infections. Clin Vaccine Immunol 22(9):1025–1032. https://doi.org/10.1128/CVI.00347-15
Vollmer AH, Gebre MS, Barnard DL (2016) Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice. Antiviral Res 133:196–207. https://doi.org/10.1016/j.antiviral.2016.08.011
Wang L (2020) C-reactive protein levels in the early stage of COVID-19. Med Maladies Infect 50(4):332–334. https://doi.org/10.1016/j.medmal.2020.03.007
Wang Q, Ding H, Tang JR et al (2009) C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. Acta Pharmacol Sin 30(3):291–298. https://doi.org/10.1038/aps.2009.14
Wang G, Wu C, Zhang Q et al (2020) C-reactive protein level may predict the risk of COVID-19 aggravation. Open Forum Infect Dis. https://doi.org/10.1093/ofid/ofaa153
Warusevitane A, Karunatilake D, Sim J et al (2016) Early diagnosis of pneumonia in severe stroke: clinical features and the diagnostic role of C-reactive protein. PLoS ONE. https://doi.org/10.1371/journal.pone.0150269
Weatherall DJ, Ledingham JGG, Warrell DA (1996) The acute phase response and C-reactive protein. Oxford textbook of Medicine, 3rd edn. Oxford University Press, New York, pp 1527–1533
Wijayasinghe YS, Bhansali P, Viola RE et al (2021) Natural products: a rich source of antiviral drug lead candidates for the management of COVID-19. Curr Pharm Des 27(33):3526–3550. https://doi.org/10.2174/1381612826666201118111151
Williams RD, Moran JA, Fryer AA et al (2020) Monomeric C-reactive protein in serum with markedly elevated CRP levels shares common calcium-dependent ligand binding properties with an in vitro dissociated form of C-reactive protein. Front Immunol 11:1–12. https://doi.org/10.3389/fimmu.2020.00115
Wu Y, Potempa LA, El Kebir D et al (2015) C-reactive protein and inflammation: conformational changes affect function. Biol Chem 396(11):1181–1197. https://doi.org/10.1515/hsz-2015-0149
Xiang P, Xu XM, Gao LL, Wang HZ, Xiong HF, Li RH et al (2020) First case of 2019 novel coronavirus disease with encephalitis. ChinaXiv T202003:00015
Xu L, He D, Bai Y (2016) Microglia-mediated inflammation and neurodegenerative disease. Mol Neurobiol 53(10):6709–6715. https://doi.org/10.1007/s12035-015-9593-4
Yao Y, Mao J, Xu S, Zhao L, Long L et al (2019) Rosmarinic acid inhibits nicotine-induced C-reactive protein generation by inhibiting NLRP3 inflammasome activation in smooth muscle cells. J Cell Physiol 234(2):1758–1767
Zhang Y, Tatewaki Y, Nakase T et al (2023) Impact of hs-CRP concentration on brain structure alterations and cognitive trajectory in Alzheimer’s disease. Front Aging Neurosci 15:1227325
Zhou Y, Zhao RH, Tseng KF, Li KP, Lu ZG, Liu Y, Han K, Gan ZH, Lin SC, Hu HY, Min DL (2016) Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression. Acta Pharmacol Sin 37(4):519–529
Zhu S, Waili Y, Qi X et al (2017) Serum C-reactive protein predicts early mortality in hospitalized patients with HBV-related decompensated cirrhosis. Medicine 96(4):5988. https://doi.org/10.1097/MD.0000000000005988
Zimmerman O, Rogowski O, Aviram G et al (2010) C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infect Dis 10:288. https://doi.org/10.1186/1471-2334-10-288
Acknowledgements
Support by Enhanced Seed Grant EF/2019-20/QE04-02 (to NKP) from Manipal University Jaipur, Rajasthan, India, is gratefully acknowledged. Financial support in the form of DST-FIST project (DST/2022/1012) from Govt. of India, is gratefully acknowledged.
Funding
No funding is available.
Author information
Authors and Affiliations
Contributions
AK, FF, GG, and NKP wrote and edited the manuscript; AS edited and contributed all the figures of the manuscript; SK and NKP assisted in editing the final version of the manuscript. The author(s) read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Ethical Approval
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Poddar, N.K., Khan, A., Fatima, F. et al. Association of mTOR Pathway and Conformational Alterations in C-Reactive Protein in Neurodegenerative Diseases and Infections. Cell Mol Neurobiol 43, 3815–3832 (2023). https://doi.org/10.1007/s10571-023-01402-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-023-01402-z